Common Contracts
2 similar Business Acquisition Agreement contracts by China Medical Technologies, Inc.
EX-4.9 2 dex49.htm BUSINESS ACQUISITION AGREEMENT, DATED AS OF FEBRUARY 6, 2007 EXECUTION FINAL BUSINESS ACQUISITION AGREEMENT dated as of February 6, 2007 by and among CHINA MEDICAL TECHNOLOGIES, INC. CMED TECHNOLOGIES LTD. SUPREME WELL INVESTMENTS...Business Acquisition Agreement • May 5th, 2020 • New York
THIS BUSINESS ACQUISITION AGREEMENT (this “Agreement”) is made and entered into as of February [ ], 2007 (“Agreement Date”), by and among China Medical Technologies, Inc., an exempt corporation incorporated under the laws of the Cayman Islands (“Capricorn”), CMED Technologies Ltd., a business company incorporated under the laws of the British Virgin Islands and a wholly owned subsidiary of Capricorn (“Capricorn Sub”), Molecular Diagnostic Technologies Limited, a business company under the laws of the British Virgin Islands (“Molecular”) and Supreme Well Investments Limited, a business company under the laws of the British Virgin Islands (“Seller”). Each of Seller and Molecular is individually referred to herein as a “Seller Party”, and collectively as the “Seller Parties.” Each of Capricorn, Capricorn Sub and each Seller Party is individually referred to herein as a “Party”, and collectively as the “Parties”.
BUSINESS ACQUISITION AGREEMENT dated as of February 6, 2007 by and among CHINA MEDICAL TECHNOLOGIES, INC. CMED TECHNOLOGIES LTD. SUPREME WELL INVESTMENTS LIMITED AND MOLECULAR DIAGNOSTIC TECHNOLOGIES LIMITEDBusiness Acquisition Agreement • September 28th, 2007 • China Medical Technologies, Inc. • Surgical & medical instruments & apparatus • New York
THIS BUSINESS ACQUISITION AGREEMENT (this “Agreement”) is made and entered into as of February [ ], 2007 (“Agreement Date”), by and among China Medical Technologies, Inc., an exempt corporation incorporated under the laws of the Cayman Islands (“Capricorn”), CMED Technologies Ltd., a business company incorporated under the laws of the British Virgin Islands and a wholly owned subsidiary of Capricorn (“Capricorn Sub”), Molecular Diagnostic Technologies Limited, a business company under the laws of the British Virgin Islands (“Molecular”) and Supreme Well Investments Limited, a business company under the laws of the British Virgin Islands (“Seller”). Each of Seller and Molecular is individually referred to herein as a “Seller Party”, and collectively as the “Seller Parties.” Each of Capricorn, Capricorn Sub and each Seller Party is individually referred to herein as a “Party”, and collectively as the “Parties”.
